NCT02203136 Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging Status COMPLETED Phase N/A
NCT02197897 Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors Status COMPLETED Phase PHASE2
NCT02188446 Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients Status COMPLETED Phase NA
NCT02186925 A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. Status UNKNOWN Phase N/A
NCT02178722 Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT02177695 S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer Status COMPLETED Phase PHASE2
NCT02174185 Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic Neobladders Status UNKNOWN Phase N/A
NCT02164942 LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer Status TERMINATED Phase N/A
NCT02153905 T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive Status TERMINATED Phase PHASE1/PHASE2
NCT02149862 FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors Status COMPLETED Phase NA
NCT02145871 A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy Status COMPLETED Phase PHASE3
NCT02145390 Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy Status TERMINATED Phase NA
NCT02143804 Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer Status WITHDRAWN Phase PHASE2
NCT02141490 Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers Status COMPLETED Phase PHASE2
NCT02113501 Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study Status COMPLETED Phase N/A
NCT02108652 A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2) Status COMPLETED Phase PHASE2
NCT02106416 Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development Status COMPLETED Phase NA
NCT02092948 Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer Status COMPLETED Phase PHASE1